november AG

euro adhoc: november AG
other
IBL reaches agreement Subsidiary of november AG goes to Meddens Diagnostic BV

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Contracts 28.07.2008 IBL Gesellschaft für Immunchemie und Immunbiologie mbH, a 100% subsidiary of november AG, Erlangen, is sold to Meddens Diagnistics BV, Amsterdam in an asset deal transaction. IBL had filed for insolvency last year. The transaction is to be concluded in the next month. end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: november AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Marcus Weichert Leitung PR/IR Telefon: +49(0)9131 75088 868 E-Mail: weichert@november.de Branche: Biotechnology ISIN: DE000A0S9N72 WKN: A0S9N7 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse Hannover / free trade Börse München / free trade

Das könnte Sie auch interessieren: